● AI Equity Research · Technology

International Business Machines Corporation (IBM)

AI stock analysis · Information Technology Services · Last analyzed Aug 19, 2026

Compass Score

3.0/5

Call

Hold

Price

$232.67

AI Target

$244.16 +4.9%

AI Analyst Summary

IBM presents a steady, if unspectacular, investment case anchored by its hybrid cloud and AI platform (watsonx), which is beginning to inflect software segment revenue. The forward P/E of 17.7x and a Buy-skewed analyst consensus suggest the market sees a credible earnings recovery path, particularly as consulting headwinds stabilize and AI-related software bookings scale. The primary risk is the persistent weakness in earnings growth (-1.8% YoY), which keeps the PEG elevated and limits near-term upside conviction.

Catalysts

Accelerating watsonx AI platform adoption — IBM's next quarterly earnings could show measurable software segment revenue acceleration as enterprise AI deployments convert from pilots to production contracts.
HashiCorp acquisition integration driving incremental recurring software revenue, with management likely to update synergy targets in the next 1–2 quarters.
Stabilization and potential recovery in the Global Consulting segment, which has faced demand softness; any improvement in book-to-bill ratio would be a meaningful positive signal.

Fundamentals

Pe Trailing P/E: 20.7x / Forward P/E: 17.7x · 4.0/5

Trailing P/E of 20.7x is modestly below the broader technology sector median, and the forward P/E of 17.7x suggests further compression as earnings recover — a reasonable valuation for a large-cap IT services incumbent.

Peg PEG Ratio: 2.38x · 2.0/5

A PEG of 2.38x signals the market is pricing in growth that current earnings momentum does not yet support. With YoY earnings declining, investors are paying a meaningful premium relative to near-term growth delivery.

Analyst Rating Buy consensus (2.1) · 4.0/5

With 23 analysts covering the stock (14 Buy / 9 Hold / 2 Sell), the consensus of 2.1 reflects a constructive but not euphoric outlook. Broad coverage and a skew toward Buy ratings indicates solid institutional conviction.

Earnings Trend EPS Growth YoY: -1.8% | Revenue Growth YoY: +1.1% · 2.0/5

Earnings declined modestly year-over-year at -1.8%, and top-line growth of just 1.1% signals a business still navigating a sluggish demand environment. The trend is not deteriorating sharply, but lacks the momentum needed for a higher score.

Price Target Beat EPS Beat Rate: 3 of 4 quarters · 4.0/5

Beating consensus EPS estimates in 3 of the last 4 quarters demonstrates consistent execution at the management level, even in a challenging revenue growth environment. Extrapolating to an 8-quarter proxy, this maps to approximately 6 of 8 — a strong beat rate.

Management Consistent executor with disciplined capital allocation · 4.0/5

IBM's management has demonstrated reliable EPS delivery, ongoing portfolio reshaping (including the Kyndryl spin-off and HashiCorp acquisition), and a sustained dividend — all signaling disciplined capital stewardship. Analyst confidence further supports a constructive management assessment.

● See the full picture

Get today's top-scored picks, ranked for you.

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Start free for 3 days →

No credit card. Then $9/month. Cancel anytime.

How Compass scores stocks

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →

Not financial advice. Compass is an analytical tool, not a registered investment adviser or broker-dealer. Scores and recommendations are generated by AI, may be inaccurate or out of date, and are not investment, financial, legal, or tax advice. Investing involves risk, including loss of principal. Do your own research and consult a licensed financial professional. About Compass.